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Background: Sudden unexplained death syndrome (SUDS) in young individuals often results from 
inherited cardiac disease. Accordingly, comprehensive examination in surviving first-degree relatives 
unmasks such disease in ~35% of families. It is unknown whether individuals from diagnosis-negative 
families are at risk of developing manifest disease or cardiac events during follow-up. 5 
Objectives: To study the prognosis of first-degree relatives of young SUDS victims, in whom the initial 
cardiologic and genetic examination did not lead to a diagnosis.  
Methods: We retrieved vital status of surviving first-degree relatives from 83 diagnosis-negative families 
who presented to our cardiogenetics department in 1996-2009 because of SUDS of ≥1 relative aged 1-50 
years. Moreover, we contacted relatives who previously visited our center for detailed information.  10 
Results: We obtained detailed information (median follow-up, 6.6 years; interquartile range, 4.7-9.6) in 
340/417 first-degree relatives (81.5%) from 77 of 83 families (92.8%). Vital status, available in 405 
relatives (97.1%), showed that 20 (4.9%) relatives died during follow-up, including one natural death 
under the age of 50. This girl belonged to a family with multiple cases of idiopathic ventricular fibrillation 
and SUDS, including another successfully resuscitated sibling during follow-up. 234 of 340 first-degree 15 
relatives (68.8%) underwent cardiologic examination. Of these, 76 (32.5%) were reevaluated. Inherited 
cardiac disease was diagnosed in 3 families (3.6%). 
Conclusion: In first-degree relatives of young SUDS victims with no manifest abnormalities during 
initial examination, the risk of developing manifest inherited cardiac disease or cardiac events during 








ICD  = implantable cardioverter-defibrillator 
IVF  = idiopathic ventricular fibrillation 




Sudden death in apparently healthy young individuals is often caused by inherited cardiac diseases.1, 2 
Consequently, the risk of cardiovascular disease and ventricular arrhythmias is higher in relatives of 
young sudden cardiac death victims, in particular relatives under the age of 35, than in the general 
population.3 In approximately 18%1 (range, 6%–35%)2, 4-9 of young sudden death cases, autopsy does not 5 
reveal the cause of death, and in many countries autopsy is not routinely performed in all of these 
fatalities. Sudden unexplained death syndrome (SUDS) is diagnosed in both cases.10  
Comprehensive cardiologic and molecular-genetic evaluation of first-degree relatives of young 
SUDS victims is indicated.11, 12 This evaluation unmasks an inherited cardiac disease, potentially 
explaining the fatal event, in approximately 35% of the families,13-16 enabling timely prophylactic 10 
treatment.17  
Relatives from SUDS victims in whom the initial comprehensive cardiologic and genetic 
examination does not lead to a familiar diagnosis are usually advised to undergo cardiologic 
reexamination on a regular basis, as inherited cardiac diseases may manifest during follow-up.10, 18, 19 
Whether cardiologic examination during follow-up unmasks previously undiagnosed inherited conditions 15 
and whether these relatives are at risk for SUDS has, to our knowledge, not been studied. Indeed, if 
relatives of an SUDS victim are carrier of an undiagnosed inherited cardiac disease, potentially fatal 
cardiac events could occur during follow-up.  
To address these issues, we carried out an observational follow-up study among first-degree 
relatives of young SUDS victims, in whom the initial cardiologic and genetic examination did not lead to 20 






Details on our multidisciplinary cardiogenetics outpatient clinic at the Academic Medical Center, 
Amsterdam, the Netherlands (teaching hospital),17 and our SUDS registry comprising families who 
underwent cardiologic and genetic examination after the SUDS of a relative aged 1–50 years (the 5 
proband), have been described in detail.15 SUDS was defined as out-of-hospital natural death in a 
previously healthy individual whose family had no known inherited cardiac disease, in whom death 
occurred within one hour after the start of complaints or within 24 hours of the victim being seen alive 
and well, and in whom autopsy was not performed or initially did not explain the death.15 In our 
cardiogenetics clinic, relatives of SUDS victims are counseled by both a cardiologist and a clinical 10 
geneticist or genetic counselor, who collect detailed information on the SUDS proband (including 
circumstances of SUDS) and the family. This is followed by tailored cardiologic examination and 
targeted molecular genetic testing. When these investigations are completed, the relatives receive a letter 
that summarizes the complete evaluation that was performed in their family. When a diagnosis is made, 
appropriate follow-up is arranged. When no diagnosis is made (diagnosis-negative family), most relatives 15 
are advised to undergo repeated cardiologic evaluation, in particular when they develop possible cardiac 
symptoms. This advice is individualized and based on the level of suspicion of an inherited cardiac 
disease and age. For example, children are usually advised to undergo yearly cardiologic evaluation, 
whereas adults are advised to undergo evaluation every three to five years. 
 20 
Study population 
This analysis comprised all surviving first-degree relatives (parent, sibling, or child) from diagnosis-
negative families of a SUDS victim aged 1-50 years, of whom ≥1 first-degree relative presented to our 





First, all first-degree relatives who had not visited our center recently were contacted by using a 
standardized questionnaire to obtain detailed information on themselves and their family. Second, we 
contacted at least one first-degree relative per family by phone for additional questioning, including on 
non-first-degree relatives. Cardiologic reevaluation, newly diagnosed (inherited) cardiac disease and the 5 
occurrence of cardiac events (defined as aborted cardiac arrest or sudden death) as well as death due to 
other causes at any age in the family were questioned. In relatives who had visited our center and 
consented, additional information was obtained from the relative’s general practitioner, cardiologist, or 
hospital records, when necessary. All the relatives who were examined within a year after the family 
came to our attention were considered to be part of the initial examination. The yield of cardiologic 10 
evaluation during follow-up included the yield of cardiologic evaluation in all relatives who were 
evaluated for the first time ≥1 year after the family came to our attention and the yield of reevaluation in 
relatives who were part of the initial examination.    
  Information on vital status of first-degree relatives in whom no detailed information could be 
collected was obtained from the Dutch national population registry and was verified until January 1, 15 
2013. This national population registry does not contain information on the cause of death.  
  Follow-up durations were counted from the date when the first relative of that family presented to 
our center to the date when information on a relative was obtained or the relative’s death.  
   
Statistical analysis 20 
Continuous data are presented as median (interquartile range) and categorical variables as number 




Ten of the 93 SUDS families who were classified diagnosis-negative SUDS after the first cardiologic 
examination15 were excluded from the present analysis: five families because only second-degree 
relatives were examined, three who were double-counted because it was found after initial analysis that 5 
they were related to each other, and two because no follow-up information, including vital status, was 
available in any relative. Hence, we included the first-degree relatives of 83 SUDS victims. Nineteen 
probands (22.9%) were aged 1 to 21 years, and autopsy was performed in 40 (48.2%) (Table 1).  
  At time of their death, the 83 SUDS victims had 417 living first-degree relatives. Complete 
detailed follow-up information was available in 63 families (75.9%), comprising 308 first-degree 10 
relatives. In 20 families (24.1%) follow-up was incomplete, with detailed follow-up information in 34 
relatives, vital status only in 61, and no follow-up information in 12. The median follow-up period was 
6.6 years (interquartile range, 4.7-9.6).  
 
Mortality  15 
Overall, vital status was retrieved in 405 of 417 relatives (97.1%; median of 4 per family [range, 1-13]) 
from all 83 families. Their median age was 41.5 years (interquartile range, 26-55) when their family first 
came to our attention, 267 relatives were below the age of 50, and 177 (44.1%) were male. During follow-
up, 20 (4.9%) relatives died, including two under the age of 50 (0.7% of this age-group). One girl died 
suddenly at the age of ten while watching television (II:5 in Figure 1; see text below), although the 20 
cardiologic evaluation that was performed three months earlier was unremarkable. A female relative from 
another family committed suicide at the age of 44. Of the 18 deceased individuals over the age of 50, 
eight died from a definite non-cardiac cause, while the cause of death was unknown in 10 relatives (of 
whom at least five were above the age of 75 years). Thus, 11 relatives (2.7%) died of cardiac or unknown 
causes.  25 
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  In addition, four sudden death events among non-first-degree related relatives were reported in 
four families: one 48-year old uncle of a SUDS proband died suddenly from an unknown cause while 
gardening; one 41-year old aunt of a SUDS proband died presumably from a ruptured abdominal aortic 
aneurysm; and a second cousin of a SUDS proband died suddenly and unexpectedly in his early forties. 
Finally, the aunt of a SUDS proband died suddenly at the age of 44 while vacuum cleaning. Autopsy 5 
revealed arrhythmogenic cardiomyopathy. Molecular-genetic testing of all genes linked to 
arrhythmogenic cardiomyopathy (PKP2, DSP, DSC2, DSG2, JUP, TMEM43, and PLN) was negative. 
 
Nonfatal cardiac events  
Detailed follow-up information was available in 340 relatives (81.5%; median of 4 per family [range, 0-10 
13]) from 77 of 83 families (92.8%). These relatives had a median age of 41 years (interquartile range, 
27-54) when their family first came to our attention, including 230 below the age of 50, and 157 (46.2%) 
were male. During follow-up, one more definite cardiac event occurred: a younger sister (II:6 in Figure 1) 
of the 10-year old girl that died suddenly, was successfully resuscitated and received an appropriate 
implantable cardioverter-defibrillator (ICD) shock after an episode of ventricular fibrillation one year 15 
later. The girls originated from a Moroccan family with an extremely malignant family history in one 
generation including multiple cases of idiopathic ventricular fibrillation (IVF) and SUDS (Figure 1). This 
family came to our attention in 2001 after the aborted cardiac arrest of a 16-year old boy (II:3). His family 
history included SUDS of his sister at the age of 9 (II:4). Consanguinity was denied. Comprehensive 
cardiologic examination in the 16-year old boy, the parents and the other children did not reveal any 20 
abnormalities. Very recently, the causal genetic substrate, a mutation in the gene encoding calmodulin 
(CALM1), was identified in all affected individuals.20 
  
Cardiologic reevaluation and inherited cardiac disease 
Of the 340 relatives with detailed follow-up information, 223 were evaluated once following the SUDS 25 
event in their family. In addition, the information of 11 relatives who underwent cardiologic examination 
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for other reasons could also be used. Thus, 234 of 340 first-degree relatives (68.8%) were part of the 
initial evaluation. Of these, 76 (32.5%) were reevaluated as recommended after the negative initial 
examination (N=66) or for another reason (N=10). The reevaluation was performed at our center or the 
referring center, so no uniform approach was applied.  
 In three families (3.6%) an inherited cardiac disease was identified during follow-up. In the first 5 
family, a brother of the 39-year-old male SUDS victim was diagnosed with Brugada syndrome. No 
autopsy had been performed in the proband. Only the daughter of the SUDS victim had previously been 
examined, and results of all tests, including ajmaline challenge, were unremarkable. The individual in 
whom Brugada syndrome was diagnosed, was cardiologically evaluated for the first time during follow-
up.  10 
 The second family underwent evaluation because of the SUDS of 42-year-old man in whom no 
autopsy was performed. Initial cardiologic examination revealed a slightly dilated aorta in the proband’s 
brother. During follow-up, minimal aorta dilatation was identified in two other brothers. In all three 
brothers and their mother a missense mutation in the TGFBR1 gene was identified. Because none of the 
relatives showed signs of Marfan syndrome or Loeys-Dietz syndrome, the final diagnosis was familial 15 
thoracic aortic aneurysms/dissections.  
 In a third family, three first-degree relatives who were aged 37 to 53 years experienced myocardial 
infarction during 10.5 years of follow-up. In addition, one relative underwent coronary artery bypass graft 
surgery. All affected relatives were diabetic and had hyperhomocysteinemia, possibly related to folate 
deficiency. Two of these relatives were part of the initial evaluation in their family. At that time, 20 
premature atherosclerosis was already suspected based on the family history, but an inherited 
dyslipidemia or definite coronary artery disease could not be identified in the evaluated relatives.  
   Finally, one first-degree relatives got an ICD implanted in his fifties, but information on the 




This study demonstrates that first-degree relatives from young SUDS victims in whom the initial 
cardiologic and genetic evaluation did not lead to a diagnosis, have a favorable prognosis. In this large 
cohort of diagnosis-negative SUDS families the cardiac event rate during follow-up was low. Importantly, 
all events that were definitely related to the SUDS of the proband occurred in one family with an 5 
extremely malignant history of IVF and SUDS. During follow-up, inherited cardiac disease manifested in 
three families (3.6%). In these families, the first relative in whom the diagnosis was made showed 
discrete, non-diagnostic abnormalities at the initial evaluation, or had not been examined before.  
 
Follow-up of patients and families with IVF or SUDS 10 
IVF or SUDS may ultimately be explained through a manifested phenotype during long-term follow-up. 
However, follow-up data of relatives of young victims of IVF or SUDS are scarce. In a study on the role 
of provocative testing with procainamide and epinephrine in IVF, Krahn and co-workers included 47 
unaffected first- and second-degree relatives of IVF and SUDS victims.21 Second-degree were only 
included when evidence suggested that more than one relative was affected. During 4.8±3.8 years of 15 
follow-up no events occurred, suggesting a favorable prognosis.  
Indeed, in the present large cohort of first-degree relatives from diagnosis-negative SUDS 
families, outcomes after a median period of over six years were favorable. Clearly the presence of 
undiagnosed inherited cardiac disease in SUDS families, including conditions that remain to be 
discovered, can never completely be excluded. However, based on the present data relatives may be 20 
reassured that the odds of such a scenario are low. Importantly, cardiac events or detection of previously 
undiagnosed inherited cardiac disease during follow-up were not observed in relatives who did not show 





Clinical implications  
Cardiac events or newly diagnosed inherited cardiac disease were only observed in siblings from a family 
with multiple cases of IVF and SUDS, relatives with subtle abnormalities at the initial cardiologic 
examination, or relatives who did not undergo cardiologic examination when members from their family 
first presented to our cardiogenetics department. Thus, following relatives with a malignant family history 5 
or the presence of subtle abnormalities at the initial examination as well as stressing the importance of (at 
least) a single evaluation for all first-degree relatives of a young SUDS victim, especially in the presence 
of possible cardiac symptoms, seems pertinent.  
Based on the favorable outcomes of the large population of adults from diagnosis-negative SUDS 
families in this study, it is conceivable that in these relatives a completely unremarkable first evaluation is 10 
sufficient to exclude the presence of an inherited cardiac disease. Thus, intensity of repeated cardiologic 
examination during follow-up may be diminished. However, in children from diagnosis-negative SUDS 
families manifestations of a particular inherited cardiac disease may develop with increasing age, so we 
still consider repeated cardiologic follow-up safe and indicated in these children.  
These recommendations are further supported by recent observations in a nationwide study from 15 
Denmark in which the incidence of cardiovascular disease in relatives of young sudden cardiac death 
victims was compared with that in the general population.3 The risks of both cardiovascular disease and 
ventricular arrhythmia among first- and second-degree of young autopsy-negative SUDS victims was 
increased among those younger than 35 years, but similar to the general population in relatives of all ages.   
 20 
Study limitations 
First, detailed follow-up information could not be collected in all relatives. To compensate for this lack of 
data, we obtained information on vital status in almost all of these relatives, so only the risk of non-fatal 
cardiac events or developing inherited cardiac disease may be underestimated.   
Second, only a minority of relatives underwent cardiologic reevaluation, most probably because 25 
they or their cardiologists felt reassured after the unremarkable results of their first evaluation. Thus, 
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inherited cardiac disease may have remained undiagnosed in families that were only evaluated once. Yet, 
the relatives that underwent reevaluation may well be those in whom cardiologic reevaluation was 
strongly recommended because of the family history and/or discrete abnormalities at the initial 
examination, making the odds of diagnosing inherited cardiac disease during follow-up higher in these 
reevaluated relatives than in other individuals.   5 
Third, first-degree relatives of the proband who died suddenly before the proband did, were not 
included in this study because of the previously outlined objectives of this study. These inclusion criteria 
introduce survival bias.    
Finally, the median follow-up duration of 6.6 years was relatively short.  
 10 
Conclusion 
In first-degree relatives of young SUDS victims with no manifest abnormalities during initial cardiologic 
examination, the risk of developing manifest inherited cardiac disease or potentially fatal cardiac events 
during follow-up is low. In adult relatives with a completely unremarkable first evaluation, repeated 
cardiologic examination during follow-up may not be necessary. This does not apply to children, adults 15 
with subtle abnormalities at the first examination, and families with a clear idiopathic inherited 
arrhythmia syndrome leading to multiple cases of IVF and SUDS.  
 13 
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N = 83 
Age, years 34 34 (6-49) 
Children (<21 years of age) 22.9 (19/83) 
Male sex  72.3 (60/83) 
Circumstances of event known 
At rest 










Autopsy performed 48.2 (40/83) 




Figure 1. Family tree of a family with multiple cases of SUDS and IVF. 
SUDS indicates sudden unexplained death syndrome; IVF, idiopathic ventricular fibrillation.    
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